Lyerly, Herbert

Recent Publications

Wang, J, Ren, X-R, Piao, H, Zhao, S, Osada, T, Premont, RT, Mook, RA, Morse, MA, Lyerly, HK, & Chen, W. (2019, February 8). Niclosamide-induced Wnt signaling inhibition in colorectal cancer is mediated by autophagy. The Biochemical Journal, 476 (3), 535-546.

Cecchini, M, Rubin, EH, Blumenthal, GM, Ayalew, K, Burris, HA, Russell-Einhorn, M, Dillon, H, Lyerly, HK, Reaman, GH, Boerner, S, & LoRusso, PM. (2019, January 29). Challenges with Novel Clinical Trial Designs: Master Protocols. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research,.

Crosby, EJ, Gwin, WR, Blackwell, K, Marcom, PK, Chang, S, Maecker, HT, Broadwater, G, Hyslop, TM, Kim, S, Rogatko, A, Lubkov, V, Snyder, JC, Osada, T, Hobeika, A, Morse, MA, Lyerly, HK, & Hartman, ZC. (2019, January 11). Vaccine-induced memory CD8+ T cells provide clinical benefit in HER2 expressing breast cancer: a mouse to human translational study. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research,.

Lyerly, HK, Osada, T, & Hartman, ZC. (2019, January). Right Time and Place for IL12: Targeted Delivery Stimulates Immune Therapy. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 25 (1), 9-11.

Mook, RA, Wang, J, Ren, X-R, Piao, H, Lyerly, HK, & Chen, W. (2019, January). Identification of novel triazole inhibitors of Wnt/β-catenin signaling based on the Niclosamide chemotype. Bioorganic & Medicinal Chemistry Letters, 29 (2), 317-321.

Qiao, G, Wang, X, Zhou, L, Zhou, X, Song, Y, Wang, S, Zhao, L, Morse, MA, Hobeika, A, Song, J, Yi, X, Xia, X, Ren, J, & Lyerly, HK. (2018, December 4). Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study. Clinical Cancer Research : an Official Journal of the American Association for Cancer Research,.

Lyerly, HK, Ren, J, Canetta, R, Kim, GH, Nagai, S, Yamaguchi, T, Hatogai, K, Katayama, H, Da Rocha Dias, S, McManus, D, Soltys, K, Yang, Z, Olopade, O, Goodman, N, Reaman, G, & Gross, T. (2018, December). Global Development of Anticancer Therapies for Rare Cancers, Pediatric Cancers, and Molecular Subtypes of Common Cancers. Journal of Global Oncology,(4), 1-11.

Wang, J, Mook, RA, Ren, X-R, Zhang, Q, Jing, G, Lu, M, Spasojevic, I, Lyerly, HK, Hsu, D, & Chen, W. (2018, November). Identification of DK419, a potent inhibitor of Wnt/β-catenin signaling and colorectal cancer growth. Bioorganic & Medicinal Chemistry, 26 (20), 5435-5442.

Zhao, Y, Qiao, G, Wang, X, Song, Y, Zhou, X, Jiang, N, Zhou, L, Huang, H, Zhao, J, Morse, MA, Hobeika, A, Ren, J, & Lyerly, HK. (2018, October 29). Combination of DC/CIK adoptive T cell immunotherapy with chemotherapy in advanced non-small-cell lung cancer (NSCLC) patients: a prospective patients' preference-based study (PPPS). Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico,.

Crosby, EJ, Lei, G, Wei, J, Yang, XY, Wang, T, Liu, C-X, Lyerly, HK, & Hartman, ZC. (2018, September 1). Augmentation of a novel adenoviral vaccine strategy by checkpoint inhibitors. AMER ASSOC CANCER RESEARCH.

View All Publications

Herbert Lyerly

Summary

Recent Publications